Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

24432 ARTÍCULOS , VIENDO DEL 19546 AL 19560

Alzheimer's disease drug discovery: Abeta and beyond

Shineman DW, Fillit HM.

Curr Alzheimer Res. 2010 May;7(3):188-9. doi: 10.2174/156720510791050939.

REVIEW: Curcumin and Alzheimer's disease

Hamaguchi T, Ono K, Yamada M.

CNS Neurosci Ther. 2010 Oct;16(5):285-97. doi: 10.1111/j.1755-5949.2010.00147.x.

The effects of APOE-ε4 on the BOLD response

Trachtenberg AJ, Filippini N, Mackay CE.

Neurobiol Aging. 2012 Feb;33(2):323-34. doi: 10.1016/j.neurobiolaging.2010.03.009. Epub 2010 Apr 20.

Rivastigmine-induced REM sleep behavior disorder (RBD) in a 88-year-old man with Alzheimer's disease

Yeh SB, Yeh PY, Schenck CH.

J Clin Sleep Med. 2010 Apr 15;6(2):192-5.

Molecular mechanisms of neurodegeneration in Alzheimer's disease

Crews L, Masliah E.

Hum Mol Genet. 2010 Apr 15;19(R1):R12-20. doi: 10.1093/hmg/ddq160. Epub 2010 Apr 22.

Amyloid-beta and mitochondria in aging and Alzheimer's disease: implications for synaptic damage and cognitive decline

Reddy PH, Manczak M, Mao P, Calkins MJ, Reddy AP, Shirendeb U.

J Alzheimers Dis. 2010;20 Suppl 2(Suppl 2):S499-512. doi: 10.3233/JAD-2010-100504.

Neuronal calcium signaling, mitochondrial dysfunction, and Alzheimer's disease

Supnet C, Bezprozvanny I.

J Alzheimers Dis. 2010;20 Suppl 2(Suppl 2):S487-98. doi: 10.3233/JAD-2010-100306.

Arterial spin labeling blood flow MRI: its role in the early characterization of Alzheimer's disease

Alsop DC, Dai W, Grossman M, Detre JA.

J Alzheimers Dis. 2010;20(3):871-80. doi: 10.3233/JAD-2010-091699.

Lipids and cognition

Morley JE, Banks WA.

J Alzheimers Dis. 2010;20(3):737-47. doi: 10.3233/JAD-2010-091576.

Inflammatory, apoptotic, and survival gene signaling in Alzheimer's disease. A review on the bioactivity of neuroprotectin D1 and apoptosis

Lukiw WJ, Bazan NG.

Mol Neurobiol. 2010 Aug;42(1):10-6. doi: 10.1007/s12035-010-8126-4. Epub 2010 Apr 23.

Are we getting to grips with Alzheimer's disease at last?

Boche D, Nicoll JA.

Brain. 2010 May;133(Pt 5):1297-9. doi: 10.1093/brain/awq099.

Causes versus effects: the increasing complexities of Alzheimer's disease pathogenesis

Mondragón-Rodríguez S, Basurto-Islas G, Lee HG, Perry G, Zhu X, Castellani RJ, Smith MA.

Expert Rev Neurother. 2010 May;10(5):683-91. doi: 10.1586/ern.10.27.

Current therapeutic targets for the treatment of Alzheimer's disease

Grill JD, Cummings JL.

Expert Rev Neurother. 2010 May;10(5):711-28. doi: 10.1586/ern.10.29.

Oxidative stress and Alzheimer's disease: dietary polyphenols as potential therapeutic agents

Darvesh AS, Carroll RT, Bishayee A, Geldenhuys WJ, Van der Schyf CJ.

Expert Rev Neurother. 2010 May;10(5):729-45. doi: 10.1586/ern.10.42.

Genetic evidence for the involvement of lipid metabolism in Alzheimer's disease

Jones L, Harold D, Williams J.

Biochim Biophys Acta. 2010 Aug;1801(8):754-61. doi: 10.1016/j.bbalip.2010.04.005. Epub 2010 Apr 24.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias